Dhierin is the developer of the AeroFuel and Cost Model, which is used in some articles as well and is freely available to premium members on AeroAnalysis. With his Aerospace Engineering background he has a more indepth knowledge about Aerospace products, so most of his articles will be about companies in the aerospace industry or airline industry, comparing products and looking at market outlooks. Dhierin has accumulated over 1,500,000 views never failing to spark healthy and thoughtful discussions for investors and aerospace professionals. AeroAnalysis offers wide variety of services, ranging from providing data and cost models to consultancy possibilities. Check out our website for more information.
Former broker, now an independent analyst/writer on Seeking Alpha and founder and editor of the Growth Stock Forum. Focusing on small-cap, mid-cap and biotech stocks. Looking for substantial sales and earnings growth potential and seeking the best risk-adjusted returns from my stock selection. Taking advantage of medium to long-term momentum.
My articles represent my personal opinion and analysis and should not be regarded as investment advice in any way. Readers and subscribers should do their own due diligence and/or consult their financial advisor before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal.
Exclusive research: http://seekingalpha.com/author/oneil-trader/research
The Clinically Sound Investor is a pharmacist with a PharmD and a BA in psychology. He has worked across the spectrum from very small independent and hospital pharmacies to the some of the largest retail corporations and medical centers in the nation, as well as experience in specialty and mail order settings. Fascinated by watching the rise of Walmart and Apple after 2008, he now follows the advice "know thyself" and puts expertise of understaning scientific literature to research biotechnology stocks. His investments early on were driven by binary events such as FDA Advisory Committee meetings and PDUFA dates (approvals). Despite initial successes, there were too few of these events, so he expanded into predicting Phase II/III trial results. His writings should not be considered financial advice or the basis for investment decisions. While his interpretations of clinical trial results--which may be overlooked or even thoroughly misunderstood by Wall Street--could be helpful, they're only as good as the original reports they come from. Although written by scientists and doctors, there will always be a slant from the sponsoring company, or worse (like, say, missing data...).
Zach is a biotech investor with PhD training in Biochemistry and Molecular Biology. In real life, he is a scientific writer specializing in continuing medical education. He hopes to provide a crucial piece of total due diligence as well as interesting insight into clinical findings that may impact readers' portfolios and lives.
Chris (firstname.lastname@example.org) is an Hon B.Sc graduate (with distinction) in Science and Economics with over 15 years in investing experience. He holds a PMP (Project Management Professional) designation. TipRanks Top 100 Blogger of 2015 (also 2013, 2014). Seeks undervalued, unappreciated value stock ideas. Follows Warren Buffet's mantra: do not lose money. For a better mobile experience on Seeking Alpha click on the top right menu icon on most browsers and select "request desktop site".
Brad Thomas is a research analyst and he currently writes weekly for Forbes and Seeking Alpha where he maintains research on many publicly-listed REITs. In addition, Thomas is the Senior Analyst at iREIT Forbes and Editor of the Forbes Real Estate Investor, a monthly subscription-based newsletter.
Thomas has also been featured in Forbes Magazine, Kiplinger’s, US News & World Report, Money, NPR, Institutional Investor, GlobeStreet, and Fox Business. He was the #1 contributing analyst on Seeking Alpha in 2014 (as ranked by TipRanks) and he is currently writing a book on the legendary investor Donald Trump.
Thomas has co-authored a book (The Intelligent REIT Investor) that is available on Amazon.
Thomas received a Bachelor of Science degree in Business/Economics from Presbyterian College where he played basketball. He resides in South Carolina with his wife and kids.
Editor for The Biotech Forum (www.biotechforumsa.com), the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune 100 firm for a decade. For Free weekly investment reports on small, attractive biotech stocks just register at www.bretjenseninvests.com
I am a personal finance and investing blogger. A software designer by profession, I have a passion for economics, business, finance and investing. My personal financial goals are to generate enough passive income to fund my retirement, and along the journey - share my experiences and help the readers.
I'm a contrarian value investor who writes about stocks I think may be undervalued. I tend to seek out stocks that seem to be hated or ignored by many in the market and try to focus on protecting the downside as much as possible.My favorite kind of company is one with lots of cash, little debt, and a bar set extremely low.
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
David Dierking is an analyst and writer focusing primarily on ETFs, mutual funds, dividend income strategies and retirement planning. He is a current contributor for Seeking Alpha, ETF Daily News, MutualFunds.com and ETFdb.com. He was also included in the panel for ETFReference.com’s “101 ETF Investing Tips from the Experts”.
If you're interested in learning more about dividend income strategies, retirement and ETF analysis, please consider following me by clicking on the "Follow" button at the top of this page next to my name.
In addition, you can find me on:
Twitter - @david_dierking
LinkedIn - David Dierking
Website - ETF Focus
I am a retired global analyst, currently busy in investing and writing articles about stocks at several investing publications and websites. I have also developed strategies for creating winning portfolios according to specific formulas.
In January 2015, I was ranked among the world’s top 10 financial bloggers according to TipRanks, which holds financial experts accountable for their recommendations by disclosing their stock ratings since 2009:
I specialize in European companies, sector and macro views. Qualitative and fundamental analysis are leading, while technical analysis may decide entry and exit points.
Analysis and comparison is done on the facts. The main sources are financial data published by companies and analyzed without prejudice and as objective as possible. Emotions are kept out of the equation.
I prefer to look at the fundamentals first and start additional research later to prevent becoming biased.
Comparing companies (with other companies) or to the sector often leads to surprising conclusions. Good might be bad and the other way around. I tell them as I see them.
Apart from the fundamentals the business strategy is also an important factor. The direction (and the results) are often the result of a good or bad strategy. Success and failure of the chosen strategy will become visible when viewed over a period of time.
Dhierin is the developer of the AeroFuel and Cost Model, which is used in some articles as well and is freely available to premium members on AeroAnalysis. With his Aerospace Engineering background he has a more indepth knowledge about Aerospace products, so most of his articles will be about companies in the aerospace industry or airline industry, comparing products and looking at market outlooks.
Dhierin has accumulated over 1,500,000 views never failing to spark healthy and thoughtful discussions for investors and aerospace professionals.
AeroAnalysis offers wide variety of services, ranging from providing data and cost models to consultancy possibilities. Check out our website for more information.